Cas:19953-58-3 2-Methyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one manufacturer & supplier

Chemical Name:2-Methyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one

CAS.NO:19953-58-3

Synonyms:CYPRIDINA LUCIFERIN ANALOGUE;2-Methyl-6-phenyl-3,7-dihydroimidazo<1,2-a>pyrazin-3-one;2-Methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one;MFCD00130107;CYPRIDINA LUCIFERIN;2-Methyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one;Imidazo[1,2-a]pyrazin-3(7H)-one, 2-methyl-6-phenyl-

Molecular Formula:C₁₃H₁₁N₃O

Molecular Weight:225.246

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:345.7±52.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.682

PSA:50.16000

Exact Mass:225.090210

LogP:0.58

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like CYPRIDINA LUCIFERIN ANALOGUE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Imidazo[1,2-a]pyrazin-3(7H)-one, 2-methyl-6-phenyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one Use and application,CYPRIDINA LUCIFERIN technical grade,usp/ep/jp grade.

Related News: ICIG has agreed to offer employment to the unit��s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland. 2-Methyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one manufacturer The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. 2-Methyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one supplier Retrogenix��s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding. 2-Methyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one vendor Alira is betting big on biometrics services by picking up Italy-based CROS NT, which has offices in Italy, London and North Carolina. The deal, for undisclosed terms, gives a boost to Alira’s direct clinical operations in Europe and access to biometrics services from the 29-year-old contract research organization. 2-Methyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one factory He pointed out that Taiwan had 10 confirmed cases, versus more than 14,000 in mainland China.